SARBANI MAITRA: Open Payments
NPI 1134360647 · FAIRFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,764 in 87 payments from 10 companies in 2025. Trend: 2023 $3,691 · 2024 $1,812 · 2025 $2,764
Food & beverage: $2,592Education: $172
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $654 |
| Vanda Pharmaceuticals Inc. | 21 | $623 |
| Alkermes, Inc. | 18 | $456 |
| Axsome Therapeutics, Inc. | 9 | $279 |
| Teva Pharmaceuticals USA, Inc. | 5 | $210 |
| Neurocrine BioSciences, Inc. | 7 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $136 |
| ABBVIE INC. | 4 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $83 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: COBENFY, FANAPT, ARISTADA, Auvelity, INGREZZA, CAPLYTA, LYBALVI, VRAYLAR.
Industry payments across CA — which companies pay providers there.
